Skip to main content

Tim Casey

07/23/2012
Chicago—After 30 months, patients with Philadelphia chromosome-positive chronic phase chronic myeloid leukemia who took bosutinib had superior efficacy and safety results compared with those who received imatinib, according to updated...
Chicago—After 30 months, patients with Philadelphia chromosome-positive chronic phase chronic myeloid leukemia who took bosutinib had superior efficacy and safety results compared with those who received imatinib, according to updated...
Chicago—After 30 months,...
07/23/2012
First Report Managed Care
04/23/2012
Compared with a year earlier, spending on medicines in the United States increased by 0.5% in 2011 to $320 billion. However, the overall per capita utilization of medicines and the per capita retail prescription usage declined last year....
Compared with a year earlier, spending on medicines in the United States increased by 0.5% in 2011 to $320 billion. However, the overall per capita utilization of medicines and the per capita retail prescription usage declined last year....
Compared with a year earlier,...
04/23/2012
First Report Managed Care
11/29/2011
Atlanta—Although <1% of patients use specialty medications, they account for 15% of drug spending. The trend is expected to continue, as numerous expensive specialty drugs have recently been approved by the US Food and Drug Administration...
Atlanta—Although <1% of patients use specialty medications, they account for 15% of drug spending. The trend is expected to continue, as numerous expensive specialty drugs have recently been approved by the US Food and Drug Administration...
Atlanta—Although <1% of...
11/29/2011
First Report Managed Care
08/22/2011
San Diego—The annual costs associated with managing patients with type 2 diabetes through a structured lifestyle intervention decreased during a 4-year period, according to results of an ongoing multicenter, randomized controlled trial. Ping...
San Diego—The annual costs associated with managing patients with type 2 diabetes through a structured lifestyle intervention decreased during a 4-year period, according to results of an ongoing multicenter, randomized controlled trial. Ping...
San Diego—The annual costs...
08/22/2011
First Report Managed Care
Feature
01/17/2011
Orlando—According to 24-month follow-up data from a phase 3, randomized, open-label, multicenter trial, 150-mg capsules of nilotinib had better results than imatinib mesylate tablets when treating adult patients with chronic phase, newly...
Orlando—According to 24-month follow-up data from a phase 3, randomized, open-label, multicenter trial, 150-mg capsules of nilotinib had better results than imatinib mesylate tablets when treating adult patients with chronic phase, newly...
Orlando—According to 24-month...
01/17/2011
First Report Managed Care
Feature
06/17/2011
Orlando—After several months of anticipation, healthcare professionals received some guidance regarding accountable care organizations (ACOs) on March 31 when the Centers for Medicare & Medicaid Services (CMS) announced proposed federal rules...
Orlando—After several months of anticipation, healthcare professionals received some guidance regarding accountable care organizations (ACOs) on March 31 when the Centers for Medicare & Medicaid Services (CMS) announced proposed federal rules...
Orlando—After several months of...
06/17/2011
First Report Managed Care
Conference Insider
08/15/2013
Chicago—An analysis of a large lifestyle change program in patients with type 2 diabetes found that diet and exercise modification can help patients, although <10% of participants were actively involved in the program. Sandra L. Jackson,...
Chicago—An analysis of a large lifestyle change program in patients with type 2 diabetes found that diet and exercise modification can help patients, although <10% of participants were actively involved in the program. Sandra L. Jackson,...
Chicago—An analysis of a large...
08/15/2013
First Report Managed Care
Conference Insider
11/18/2010
St. Louis—At a satellite symposium at the AMCP meeting, a trio of speakers discussed the use of biologics in chronic diseases as well as the different pharmacy benefit designs, opportunities, challenges, trends, and costs associated with the...
St. Louis—At a satellite symposium at the AMCP meeting, a trio of speakers discussed the use of biologics in chronic diseases as well as the different pharmacy benefit designs, opportunities, challenges, trends, and costs associated with the...
St. Louis—At a satellite...
11/18/2010
First Report Managed Care
Newsfeed
02/15/2011
Anaheim—To decrease the risk of patients with acute coronary syndrome (ACS) experiencing future coronary episodes, researchers are looking at the effectiveness of dual antiplatelet therapy. There are also emerging strategies such as triple...
Anaheim—To decrease the risk of patients with acute coronary syndrome (ACS) experiencing future coronary episodes, researchers are looking at the effectiveness of dual antiplatelet therapy. There are also emerging strategies such as triple...
Anaheim—To decrease the risk of...
02/15/2011
First Report Managed Care
07/22/2014
Irritable bowel syndrome (IBS), is a disorder associated with abdominal pain and discomfort and an altered bowel habit.
Irritable bowel syndrome (IBS), is a disorder associated with abdominal pain and discomfort and an altered bowel habit.
Irritable bowel syndrome (IBS),...
07/22/2014
First Report Managed Care